We’re here to help you get started in treating your patients with bispecific therapy for relapsed or refractory multiple myeloma (RRMM)

We understand that treating RRMM with bispecific therapies involves unique steps for your facility, care team, and patients. To support your success, we’ve created easy-to-follow resources for you and your patients.

Prepare Your
Facility

Prepare Your
Providers & Care Team

Prepare Your
Patients & Care Partners

Need more?

Access the RRMM bispecifics Resource Library from Johnson & Johnson for tools to support your operational readiness.

A group of researchers using advanced technology in a lab to develop innovative treatments

Learn more about the bispecific antibody therapies for RRMM from Johnson & Johnson.

Learn more

Have additional questions about the operational process of treating RRMM with bispecifics?

Learn more